Sign in to view content

Cooling Anesthesia for Intravitreal Injection With a Novel Device: Results of the Prospective COOL-2 Study

Daniel L Chao, MD, PhD

Video
Published 2020

Related

Outcomes of Patients with DME and Baseline BCVA 20/50 or Worse or 20/40 or Better Treated with Aflibercept 8 mg and 2 mg in the Phase 2/3 PHOTON Trial
Diana V Do, MD, FASRS
Updates from the Field
2024
Board-Certified Providers Are Associated With a Reduced Risk of Endophthalmitis After Intravitreal Injections
Geoffrey G. Emerson, MD, PhD, FASRS
Annual Meeting Talks
2021
Intraocular Pressure Elevation Immediately Following High-Volume (0.07 mL-0.15 mL) vs Standard Volume (0.05 mL) Injections
Scott D Walter, MD, MSc, FASRS
Annual Meeting Talks
2024

Category: Instrumentation and Devices

See more